Keywords: Parkinson's disease (PD); Subtype; Tremor-dominant (TD); Postural instability/gait difficulty (PIGD); Akinetic-rigid (AR); AR; akinetic-rigid; OR; odds ratios; PD; Parkinson's disease; PIGD; postural instability/gait difficulty; UPDRS; the Unified Parkins
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: BGTC loop; basal ganglia-thalamocortical loop; CVA; cerebrovascular accident; MRI; magnetic resonance imaging; MSA-P; multiple system atrophy Parkinsonian type; PD; Parkinson's disease; SLD; stuttering-like dysfluency; T2WI; T2-weighted imaging; TBI; tr
Keywords: AES; Articulatory Error Score; AOS; Apraxia Of Speech; agPPA; Agrammatic/Nonfluent PPA; AQ; Aphasia Quotient; ASRS; Apraxia of Speech Severity Rating Scale; BNT; Boston Naming Test; FAB; Frontal Assessment Battery; FBI; Frontal Behavioral Inventory; ICN;
Keywords: AC; anterior commissure; BEDPOSTX; Bayesian estimation of diffusion parameters obtained using sampling techniques X; BET; brain extraction tool; CI; confidence interval; CON; connectivity; DBS; deep brain stimulation; DF; degrees of freedom; DICOM; digita
Keywords: DLB; dementia with Lewy bodies; EEG; electroencephalogram; IRBD; idiopathic RBD; LC; locus coeruleus; LDT; laterodorsal tegmentum; MCI; mild cognitive impairment; MRF; mesencephalic reticular formation; MSA; multiple system atrophy; Msec; millisecond; PD;
Keywords: Healthcare; Parkinson Disease diagnosis; UPDRS; Clustering; Dimensionality reduction; ISVR;
Keywords: DBS; deep brain stimulation; DCI; decarboxylase inhibitor; ESS; Epworth Sleepiness Scale; FOG-Q; Freezing of Gait Questionnaire; ISD; istradefylline; LEDD; levodopa equivalent daily dose; PD; Parkinson's disease; PDQ 39; Parkinson's Disease Questionna
Keywords: Complementary and alternative medicine; Parkinson's disease; UPDRS; Qigong; Turo;
Keywords: BDI; Beck's Depression Inventor; Cp; ceruloplasmin; CSI; copper status indexes; FAB; Frontal Assessment Battery; H&Y; Hoehn and Yahr stage; HADS; Hospital Anxiety and Depression Scale; IL-6; interleukin-6; NMS PD; Non-Motor Symptoms Scale for Parkinsonâ
Keywords: BAI; Beck anxiety inventory; BDI-II; Beck depression inventory version II; BFRT; Benton facial recognition test; BOLD; bloodâoxygen-level dependent; COMT; catechol-O-methyltransferase; EPI; echo planar imaging; fMRI; functional magnetic resonance imagin
Keywords: ACD; anemia of chronic diseases; AD; Alzheimer's disease; AI; anemia of inflammation; AS; arterial stiffness; AUC; area under the curve; AUCROC; the area under the receiver operating characteristic curve; CAD-; coronary artery disease; CD; Crhon's dis
Keywords: Schizophrenia; Parkinson's disease; Antipsychotic drugs; Axial parkinsonian signs; APs; antipsychotic drugs; DDD; defined daily dose; DIP; Drug-induced parkinsonism; DRBA; dopamine receptor blocking agents; 123I-FP-CIT SPECT; single photon emission comput
Keywords: ABC; activities-specific balance confidence; CCMA; central control of mobility in aging; EPS; extrapyramidal signs; FoF; fear of falling; GDS-15; geriatric depression scale-15; GHS; global health score; HRs; hazard ratios; PD; Parkinson's disease; PIGD;
Keywords: PD; Parkinson's disease; EMG; electromyography; SWAL-QOL; swallow quality of life; UPDRS; Unified Parkinson's Disease Rating Scale; QOL; quality of life; OPD; oropharyngeal dysphagia; HD; high dosage group; LD; low dosage group; AUC; area under the curve;
Keywords: Parkinson's disease; Neurotrophic therapy; Clinical trials; Systematic review/meta-analysis; Neurotrophic factors; CI; confidence interval; DA; dopaminergic/dopamine; GDNF; glial cell line-derived neurotrophic factor; NTF; neurotrophic factor; NTN; neurtu
Keywords: ADRC; Alzheimer's Disease Research Center; AFNI; Analysis of Functional NeuroImages; BET; brain extraction tool; DWI; diffusion-weighted imaging; FA; fractional anisotropy; FLAIR; fluid attenuated inversion recovery; FOV; field of view; FSL; Oxford Centre
Keywords: BV; bee venom; BVA; bee venom acupuncture; BVT; bee venom therapy; MPTP; 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine; PD; Parkinson's disease; SN; substantia Nigra; UPDRS; United Parkinson's Disease Rating Scale; Complementary therapies; Dopaminergi
Keywords: AboA; abobotulinumtoxinA; BoNT; botulinum neurotoxin; DyT; dystonic tremor; EMG; electromyography; ET; essential tremor; IncoA; incobotulinumtoxinA; NIHCGC; National Institutes of Health Collaborative Genetic Criteria; OL; open label; OnaA; onabotulinumto
Keywords: Progressive supranuclear palsy; Natural history; Survival; MMSE; mini-menal state examination; PSP; progressive supranuclear palsy; TMT-A and B; trail making test A and B; UPDRS; unified Parkinon's disease rating scale;
Keywords: Exercise therapy; Gait; Neurological rehabilitation; Parkinson disease; Postural balance; Rehabilitation; H&Y; Hoehn & Yahr; PD; Parkinson disease; UPDRS; Unified Parkinson's Disease Rating Scale;
Keywords: Parkinson disease; Physical examination; Posture; Psychometrics; Rehabilitation; Reproducibility of results; HY; Hoehn and Yahr; ICC; intraclass correlation coefficient; MDC95; minimal detectable change based on 95% confidence interval; PD; Parkinson dise
Keywords: AD; Alzheimer disease; ATP; adenosine triphosphate; AMP; adenosine monophosphate; AMPK; AMP-activated protein kinase; BDNF; brain derived neurotrophic factor; CMA; chaperone-mediated autophagy; CR; caloric restriction; Ex; exercise; GABA; gamma-aminobutyr
Keywords: BH4; Tetrahydrobiopterin; CSF; Cerebrospinal fluid; HVA; Homovanillic acid; L-Dopa; L-3,4-dihydroxyphenylalanine; PRL; Prolactin; UPDRS; Unified Parkinson's Disease Rating Scale;
Keywords: Parkinson's disease; motor disorders; UPDRS; voice; acoustic;
Keywords: ABC; Activities-Specific Balance Confidence Scale; ACE; Addenbrooke's Cognitive Examination; PD; Parkinson's disease; TUG; Timed up and Go test; UPDRS; Unified Parkinson's Disease Rating Scale; Parkinson's disease; Motor control; Falls; Quality of
Keywords: Finger tapping; UPDRS; Disease severity; Tremor; Rigidity;
Keywords: ET; essential tremor; PD; Parkinson's disease; ET-NC; ET with normal cognition; ET-MCI; ET with mild cognitive impairment; ET-D; ET with dementia; ESS; Epworth Sleepiness Scale; PSQI; Pittsburgh Sleep Quality Index; UPDRS; Unified Parkinson's Disease Rati
Keywords: Cerebrospinal fluid; DaTSCAN; Normal pressure hydrocephalus; Parkinsonism; UPDRS; Ventriculoperitoneal shunt; CSF; Cerebrospinal fluid; DaT; Dopamine transporter; DaTSCAN; 123I-Ioflupane-cerebral SPECT; FAB; Frontal Assessment Battery; iNPH; Idiopathic no
Keywords: 2D; two-dimensional; BP; blood pressure; BRS; Baroreflex sensitivity; COMPASS; Composite Autonomic Symptom Score; CPET; cardiopulmonary exercise test; FEV1; volume in one second; FVC; forced vital capacity; H/M; heart-to-mediastinum; HR; heart rate; HRV;
Keywords: 6MFU; 6 months follow-up; ADL; activities of daily living; DBS; deep brain stimulation; LEDD; Levodopa equivalent daily dose; NMS; non-motor symptoms; NMSS; NMS Scale; NMSQ; NMS questionnaire; PD; Parkinson's disease; PDQ; PD questionnaire; QoL; quality o
Keywords: Parkinson disease; Psychometrics; Quality of life; Rehabilitation; AES; Apathy Evaluation Scale; ADL; activities of daily living; BDI-II; Beck Depression Inventory-II; CI; confidence interval; HRQOL; health-related quality of life; MMSE; Mini-Mental Sta
Keywords: Anosognosia; Self-awareness; Parkinson's disease; Dyskinesia; Neurodegenerative disorder; BDI-2; Beck-Depression-Inventory 2; DRT; dopamine replacement therapy; FDG; 18F-2fluoro-2-deoxy-d-glucose; FWE; family-wise error; IFG; inferior frontal gyrus; ISA;
Keywords: Dopamine; Exercise; Parkinson disease; Physical activity; PET; Sedentariness; CHAMPS; Community Health Activities Model Program for Seniors questionnaire; DTBZ; dihydrotetrabenazine; LED; levodopa equivalent dose; PD; Parkinson disease; PET; positron emis
Keywords: BMI; body mass index; PD; Parkinson's disease; STN-DBS; subthalamic nucleus deep brain stimulation; UPDRS; Unified Parkinson's disease Rating Scale; CAPIT; core assessment program for intracerebral transplantation; MDRS; Mattis Dementia Rating Scale score
Keywords: Olfactory bulb and tract volume; Olfactory dysfunction; MRI; Parkinsonism; meta-iodobenzylguanidine (123I-MIBG) scintigraphy; OSIT-J; odor stick identification test for Japanese; UPDRS; unified Parkinson's Disease Rating Scale; 123I-MIBG scintigraphy; met
Keywords: ADC; apparent diffusion coefficients; ATR; anterior thalamic radiation; CST; corticospinal tract; DTI; diffusion tensor image; DWI; diffusion weighted image; FA; fractional anisotropy; IFOF; inferior fronto-occipital fasciculus; MCP; middle cerebellar ped
Keywords: ASAs; anticipatory synergy adjustments; DPMs; distributed processing modules; ICS; impaired control of stability; PD; Parkinson's disease; UCM; uncontrolled manifold; UPDRS; Unified PD Rating Scale; stability; synergy; anticipatory synergy adjustments;
Keywords: Basal ganglia; Deep brain stimulation; Parkinson's disease; Emotional prosody; Subthalamic nucleus; 18FDG-PET; 18Fludeoxyglucose-Positron emission tomography; BG; basal ganglia; DBS; deep brain stimulation; F0; fundamental frequency; FFA; face fusiform ar
Keywords: DBS; deep brain stimulation; EEG; electroencephalography; ERD; event-related desynchronization; iCOH; imaginary part of coherency; iCOHd; detectability of imaginary part of coherency; iCOHdav; detectability of imaginary part of coherency averaged within d
Keywords: Droxidopa; Parkinson's disease; Motor fuction; Add-on; Norepinnehrine; CGI; Clinical Global Impression rating score; FAS; full analysis set; ITT; intent-to-treat; l-DOPA; Levodopa; l-DOPS; l-threo-3,4-dihydroxyphenylserine; NE; norepinnehrine; PD; Parki
Keywords: Gait analysis; Principal Component Analysis; Gait velocity; UPDRS; Parkinson's disease;
Keywords: Parkinson's disease; Pedaling; Postural instability; UPDRS;
Keywords: STN; subthalamic nucleus; PD; Parkinson's disease; FOG; freezing of gait; EEG; electroencephalography; DBS; deep brain stimulation; LFP; local field potential; UPDRS; unified Parkinson's disease rating scale; CT; computerized tomography; MR; magnetic reso
Keywords: PD; Parkinson's disease; SBT; split-belt treadmill; UPDRS; Unified Parkinson's Disease Rating Scale; AP-GRF; anterior-posterior ground reaction force; Parkinson's disease; Adaptation; Split-belt treadmill; Dopamine; Motor learning;
Keywords: Parkinson; Rapid alternating movement; RAM; Motor; UPDRS; Internally generated; Basal ganglia;
Keywords: Parkinson's disease; UPDRS; Telemedicine; Motor; Reliability; Validity; CALM-PD;
Keywords: STN-DBS; subthalamic nucleus deep brain stimulation; STN; subthalamic nucleus; PD; Parkinson's disease; UPDRS; Unified Parkinson's Disease Rating Scale; HOA; healthy older adult; STN-DBS; Movement amplitude; Movement rate; Repetitive finger movement;
Keywords: Exercise; Parkinson disease; Rehabilitation; Running; BW; body weight; MDS; Movement Disorders Society; PD; Parkinson's disease; PDQ-39; Parkinson's Disease Questionnaire-39 items; UPDRS; Unified Parkinson's Disease Rating Scale;
Keywords: PD; Parkinson's disease; DBS; deep brain stimulation; GPi; internal segment of globus pallidus; STN; subthalamic nucleus; UPDRS; Unified Parkinson's Disease Rating Scale; IPG; implantable pulse generator; Parkinson's disease; Deep brain stimulation; Brady
Keywords: LFP; local field potential; UPDRS; Unified Parkinson's Disease Rating Scale; Basal ganglia; Subthalamic nucleus; Local field potentials; Force decrement; Force release;